IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 352 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,004,300 | +187.6% | 105,000 | +264.5% | 0.04% | +1300.0% |
| Q4 2019 | $1,740,000 | +622.0% | 28,809 | +615.2% | 0.00% | -75.0% |
| Q3 2019 | $241,000 | -94.3% | 4,028 | -92.2% | 0.01% | -94.4% |
| Q1 2019 | $4,217,000 | -20.5% | 51,950 | -64.1% | 0.22% | -57.3% |
| Q3 2016 | $5,305,000 | – | 144,790 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sicart Associates LLC | 367,360 | $14,768,000 | 10.67% |
| BB BIOTECH AG | 7,461,295 | $299,944,000 | 9.81% |
| TANAKA CAPITAL MANAGEMENT INC | 83,399 | $3,353,000 | 7.39% |
| DOWLING & YAHNKE LLC | 675,843 | $27,169,000 | 2.89% |
| Opus Point Partners Management, LLC | 78,900 | $3,172,000 | 2.35% |
| Motley Fool Asset Management LLC | 259,000 | $10,412,000 | 2.25% |
| ARK Investment Management | 127,563 | $5,128,000 | 1.48% |
| Motley Fool Wealth Management, LLC | 325,965 | $13,104,000 | 1.26% |
| PINNACLE ASSOCIATES LTD | 1,514,710 | $60,891,000 | 1.16% |
| Bellevue Group AG | 205,253 | $8,251,000 | 1.10% |